Creating cancer therapies based around natural killer cells could offer similar levels of efficacy to CAR-T therapies, but at around one hundredth of the cost. Researchers at MD Anderson Cancer ...

With its breakthrough dual-targeted natural killer cell therapy platform, ONK Therapeutics is creating its own pipeline of cell therapy candidates, and seeks to further unlock its potential ...